Protalix BioTherapeutics, Inc. (PLX) Operating Lease, Liability USD 2018 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Protalix BioTherapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from 2018 to 2023.
  • Protalix BioTherapeutics, Inc. Operating Lease, Liability for the quarter ending December 31, 2023 was $6.03 M, a 14.1% increase year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $6.03 M +$743 K +14.1% Dec 31, 2023 10-K 2024-03-14
Q4 2022 $5.29 M -$296 K -5.3% Dec 31, 2022 10-K 2023-02-27
Q4 2021 $5.58 M -$304 K -5.16% Dec 31, 2021 10-K 2022-03-31
Q4 2020 $5.89 M +$187 K +3.28% Dec 31, 2020 10-K 2021-03-30
Q4 2019 $5.7 M $0 0% Dec 31, 2019 10-K 2021-03-30
Q3 2019 $5.75 M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $5.79 M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $5.76 M Mar 31, 2019 10-Q 2019-05-06
Q4 2018 $5.7 M Jan 1, 2019 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.